|Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers||
||8||All||18 Years and older (Adult, Older Adult)||NCT00848783||07-837
|May 2008||August 2011||September 2012||February 20, 2009||January 8, 2018||December 10, 2012||
|2||NCT02366819||Recruiting||Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer||
||Other / NIH||
||36||All||18 Years and older (Adult, Older Adult)||NCT02366819||IRB14-0594
|December 2014||January 2019||January 2019||February 19, 2015||February 7, 2018||
† Study has passed its completion date and status has not been verified in more than two years.